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The objective of this review is to determine the best available evidence related to the effect of insulin 
therapy algorithms on blood glucose levels in patients in critical care environments following cardiac 
surgery. 
More specifically, the review question to be answered is: 
Among adults within critical care environments who are in the acute postoperative phase (5 days) 
following cardiac surgery, what is the effect of insulin therapy algorithms for the control of blood glucose 
levels? 
Background 
Hyperglycemia, a condition characterized by elevated blood glucose levels (BGLs), is most commonly 
associated with diabetic illness.
1
 However, hyperglycemia has also been found to have a high incidence 
after cardiac surgery. Current literature surrounding this topic suggests that hyperglycemia occurs 
almost universally after cardiac surgery; irrespective of whether a person has a pre-existing diagnosis of 
diabetes mellitus or not.
1-3
 Conventionally, post-operative hyperglycemia following cardiac surgery was 
viewed purely as a natural adaptive physiological response of the body that was treated only when 
BGLs rose to what was considered excessively high levels;
2
 generally greater than 12.2 mmol/L 
[220mg/dl].
4
 This view has since changed and hyperglycemia following cardiac surgery is now viewed 
as an adverse effect of surgery, occurring as a result of multiple factors that include: the intraoperative 
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hypothermic state, surgical stress, hypokalemia, adverse effects from pharmacological agents and the 
commonly occurring post-operative systemic inflammatory response.
5-7 
While generally only transient, an incidence of hyperglycemia during the initial post-operative period 
can have serious detrimental side effects following cardiac surgery such as deep sternal wound 
infection and an increased risk of mortality.
8
 Current evidence suggests that within critical care 
environments, the early recognition and treatment of post-operative hyperglycemia is imperative. This is 
achieved through the utilization of continuous intravenous insulin infusion algorithms, with the aim of 
maintaining BGLs within normal to near normal ranges, in order to prevent the adverse outcomes 
associated with hyperglycemia in post-operative patients.
9 
The practice of maintaining BGLs within strict pre-defined levels, via the administration and titration of a 
continuous insulin infusion, has become common practice within critical care environments over the 
past decade.
10
 Results from a study by Van Den Berghe et al., which included 970 cardiac surgery 
patients [63%] showed that the maintenance of BGLs below 110 mg/dl [6.1 mmol/L], using continuous 
insulin therapy lead to decreases in both mortality and morbidity rates among critically ill surgical 
patients.
3
 Since this time, multiple studies investigating the effects of continuous insulin infusion 
algorithms have concluded that the use of such algorithms for the management of BGLs in cardiac 
surgery patients has favorable effects, decreasing the incidence of post-operative complications and 
reducing the length of time patients are required to remain in hospital.
11 
The use of continuous intravenous infusion algorithms for controlling BGLs in critically ill patients is 
further supported by the American Diabetes Association [ADA] who recommend the use of tried and 
tested insulin infusion protocols that demonstrate a low incidence of hypoglycemia.
12
 The ADA go on to 
state that BGLs of critically ill patients, including postoperative patients who have undergone a cardiac 
procedure, should be maintained between 7.8 and 10 mmol/L [140 and 180mg/dl] with insulin therapy 
commenced at a threshold no higher than 10 mmol/L [180mg/dl].
12
 While it is acknowledged that greater 
benefits may be achieved by the maintenance of BGLs at the lower ends of the range, the American 
Diabetes Association do not recommend targets less than 6.1mmol/l [110mg/l] due the high risk of 
causing significant hypoglycemia.
12 
A review of the literature shows that a number of insulin infusion algorithms, with varying methods and 
effects, have been developed for utilization by clinicians in critical care environments to guide the 
management of hyperglycemia. Due to the conflicting evidence that currently exists, the critical care 
clinician responsible for the provision of care to post-operative cardiac surgery patients needs to 
determine the best evidence in relation to the management of hyperglycemia, to maintain patient safety 
and ensure good surgical outcomes, free from complications. However, a review of the outcomes of 
these protocols for cardiac patients has not been published to inform the development of best evidence 
based practice guidelines. This systematic review therefore aims to review the various protocols to 
ascertain the best available evidence related to the effect of intensive insulin therapy algorithms on 
BGLs in post-operative patients in critical care environments following cardiac surgery. 
Keywords 
Hyperglycemia/hyperglycaemia; Blood glucose; Cardiac surgery; Heart surgery; Insulin; Insulin 
infusion; Intensive insulin infusion; Intravenous insulin infusion; Continuous insulin infusion; 
Postoperative; Critical care environment 
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Inclusion criteria 
Types of participants 
This review will consider studies that include adult patients aged 18 years and over admitted to a critical 
care unit following cardiac surgery and who received insulin therapy for glycemic control during the 
acute postoperative phase (five days) of admission. 
In this review studies that include participants with a known diagnosis of Diabetic Ketoacidosis will be 
excluded. 
Types of intervention(s)/phenomena of interest 
This review will consider studies that evaluate the use of intravenous insulin therapy algorithms to 
control blood glucose levels in acute postoperative phase patients in critical care environments 
following cardiac surgery.   
In this review, studies will be included if they make one of the following comparisons: 
1. Intravenous insulin therapy algorithm compared to another insulin therapy algorithm. 
2. Intravenous insulin therapy algorithm compared to no treatment. 
3. Intravenous insulin therapy algorithm compared to a placebo. 
In this review, studies that include a Glucose-Insulin-Potassium (GIK) infusion as an intervention or a 
comparator will be excluded. 
Types of outcomes 
This review will consider studies that include the following outcome measures: 
Primary outcome: 
 Overall control of blood glucose levels as measured by time to target BGL range, time spent in 
BGL target range and time above or below target BGL range.  
Secondary outcome: 
 Incidence of adverse events, including: 
- Hypo/hyper glycemia, measured by standard point of care glucometers, arterial blood 
analysis, or venous blood analysis, with hypoglycemia defined as a BGL reading <3.9mmol/L 
(70mg/dL)
13
 and hyperglycemia defined as a BGL reading >7.8mmol/L(140mg/dL).
13
 
- Sternal wound infection, identified by a positive wound culture or a positive wound exudate 
        culture.
14 
- Mortality rate measured by in-hospital mortality (from day of operation to day of discharge) 
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Types of studies 
This review will consider any experimental study design including randomized controlled trials, 
non-randomized controlled trials, quasi-experimental and before and after studies for inclusion. 
Search strategy 
The search strategy aims to find both published and unpublished studies. A three-step search strategy 
will be utilized in this review. An initial limited search of MEDLINE and CINAHL will be undertaken, 
followed by analysis of the text words contained in the title and abstract and of the index terms used to 
describe the article. A second search using all identified keywords and index terms will then be 
undertaken across all included databases. Thirdly, the reference lists of all identified reports and articles 
will be hand searched for additional studies.  
Studies published in the English language will be considered for inclusion in this review. Databases will 
be searched with no limits placed on the date of publication, allowing authors to search as far back as 
possible. 
The databases to be searched include:  
MEDLINE, CINAHL, PubMed, Embase, SCOPUS, Cochrane Trials, Dare, Social Science Index.  
The search for unpublished studies will include:  
ProQuest Dissertations & Theses and MedNar 







Intensive insulin infusion 
Intravenous insulin infusion 
Continuous insulin infusion 
Postoperative 
Critical care environment 
Assessment of methodological quality 
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity 
prior to inclusion in the review using standardized critical appraisal instruments from the Joanna Briggs 
Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix I). 
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Any disagreements that arise between the reviewers will be resolved through discussion, or with a third 
reviewer. 
Data collection 
Data will be extracted from papers included in the review using the standardized data extraction tool 
from JBI-MAStARI (Appendix II). The data extracted will include specific details about the interventions, 
populations, study methods and outcomes of significance to the review question and specific 
objectives. 
Data synthesis 
Quantitative data will, where possible, be pooled in statistical meta-analysis using JBI-MAStARI. All 
results will be subject to double data entry. Effect sizes expressed as odds ratios (for categorical data) 
and weighted mean differences (for continuous data) and their 95% confidence intervals will be 
calculated for analysis. Heterogeneity will be assessed statistically using the standard Chi-square and 
also explored using subgroup analyses based on the different study designs included in this review. 
Where statistical pooling is not possible, the findings will be presented in narrative form including tables 
and figures to aid in data presentation where appropriate. 
Conflicts of interest 
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Appendix I: Appraisal instruments 
MAStARI appraisal instrument 
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Appendix II: Data extraction instruments 
MAStARI data extraction instrument 
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